RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Scott to Camptothecin

Back to Details
This is a "connection" page, showing publications John Scott has written about Camptothecin.
John Scott
Connection Strength
0.404
Camptothecin
  1. Ahmad S, Hughes MA, Yeh LA, Scott JE. Potential repurposing of known drugs as potent bacterial ?-glucuronidase inhibitors. J Biomol Screen. 2012 Aug; 17(7):957-65.
    View in: PubMed
    Score: 0.377
  2. Kong R, Liu T, Zhu X, Ahmad S, Williams AL, Phan AT, Zhao H, Scott JE, Yeh LA, Wong ST. Old drug new use--amoxapine and its metabolites as potent bacterial ?-glucuronidase inhibitors for alleviating cancer drug toxicity. Clin Cancer Res. 2014 Jul 01; 20(13):3521-30.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support